A single center, randomized, double-blind, placebo-controlled, single and multiple-dose study of DEB025 (alisporivir) in healthy Chinese and Caucasian subjects

Trial Profile

A single center, randomized, double-blind, placebo-controlled, single and multiple-dose study of DEB025 (alisporivir) in healthy Chinese and Caucasian subjects

Suspended
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Alisporivir (Primary)
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Jul 2013 Status changed from not yet recruiting to suspended as reported by Clinical Research Information Service (CriS) - Republic of Korea.
    • 20 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top